(Q34467208)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Nazarii Kobyliak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Marcello Persico

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Ludovico Abenavoli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Valentina Peta

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Natasa Milic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Samir Rouabhia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

English

0 references

publication date

1 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

number of pages

8

1 reference

World Journal of Gastroenterology

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

15233-15240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

Treatment of hepatitis C virus genotype 3-infection

22 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Sofosbuvir for previously untreated chronic hepatitis C infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

The predictive value of steatosis in hepatitis C virus infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

HCV and oxidative stress in the liver.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Insulin resistance impairs viral dynamics independently of ethnicity or genotypes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Steatosis and insulin resistance in response to treatment of chronic hepatitis C.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Treatment of patients with genotype 3 chronic hepatitis C--current and future therapies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepatitis C

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Hepatic steatosis and hepatitis C: Still unhappy bedfellows?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Insulin resistance, hepatic steatosis and hepatitis C: a complex relationship with relevant clinical implications.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Abnormalities of lipid metabolism in hepatitis C virus infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Steatosis and insulin resistance in hepatitis C: a way out for the virus?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Molecular mechanisms of insulin resistance in chronic hepatitis C

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Gene expression profile of Huh-7 cells expressing hepatitis C virus genotype 1b or 3a core proteins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Hepatitis C virus infection: molecular pathways to metabolic syndrome

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Specific Polymorphisms in Hepatitis C Virus Genotype 3 Core Protein Associated with Intracellular Lipid Accumulation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Enhancement of de novo fatty acid biosynthesis in hepatic cell line Huh7 expressing hepatitis C virus core protein

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4223256

Antiviral treatment of hepatitis C virus infection and factors affecting efficacy

6 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Type 2 diabetes mellitus in chronic hepatitis C virus infection: risk factor or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Steatosis as a co-factor in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Role of insulin resistance and hepatic steatosis in the progression of fibrosis and response to treatment in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Chronic hepatitis C infection and insulin resistance: two best friends

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Hyperinsulinaemia reduces the 24-h virological response to PEG-interferon therapy in patients with chronic hepatitis C and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Meta-analysis: insulin resistance and sustained virological response in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V20.I41.15233

Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25386071

12 December 2020

inferred from PubMed ID database lookup

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25386071

12 December 2020

inferred from PubMed ID database lookup

[Possible mechanism of the regulation of smooth muscle relaxation by calcium ions]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25386071

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.3748/WJG.V20.I41.15233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

25386071

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25386071%20AND%20SRC:MED&resulttype=core&format=json